Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John Flaherty, PharmD
Gilead Sciences
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
111 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Univ.-Kklinik Fuer Innere Medizin Iii
Salzberg, Austria
- Lkh Graz West
Styria, Austria
- 2.Interne Lungenabteilung Otto Wagner Spital
Vienna, Austria
- Dept. of Dermatology, Div. of Immunology,
Vienna, Austria
- Private Office
Vienna, Austria
- Chu Saint-Pierre University Hospital
Brussels, Belgium
- University Hospitals Leuven
Flemish Brabant, Belgium
- Universitaire Ziekenhuis Gent
Ghent, Belgium
- Downtown Infectious Disease Clinic - Univ of Bc
Vancouver, British Columbia, Canada
- Maple Leaf Research
Toronto, Ontario, Canada
- Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
- Clinique Medicale Du Quartier Latin
Montreal, Quebec, Canada
- Winnipeg Regional Health Authority
Winnipeg, Canada
- Hôpital Hôtel-Dieu
Lyon, France
- Infectiologie - 7ème Ouest - Chu Hotel Dieu
Nantes, France
- Archet 1 Chu de Nice - 6ème Niveau - Infectiology
Nice, France
- Bichat Hospital
Paris, France
- Department of Infectious Diseases, Saint-Louis Hospital
Paris, France
- Hopital Tenon
Paris, France
- Hôpital Saint Antoine, Servuce de Maladies Infectieuses
Paris, France
- Maladies Infectieuses Dpt
Paris, France
- Hôpital Haut Levêque
Pessac, France
- Epimed Gmbh
Berlin, Germany
- University of Bonn, Dep. of Internal Medicine I, Hiv-Outpatient Clinic
Bonn, Germany
- University of Cologne, Department of Internal Medicine
Cologne, Germany
- Center for Hiv and Hepatogastroenterology
Düsseldorf, Germany
- Infectio Research
Frankfurt, Germany
- Ich Study Center Hamburg
Hamburg, Germany
- University Medical Center Hamburg - Eppendorf
Hamburg, Germany
- Ospedali Riuniti
Bergamo, Italy
- Azienda Ospedaliera Luigi Sacco 1° Divisione Malattie Infettive
Milan, Italy
- Azienda Ospedaliera San Paolo, Mallattie Infettive E Tropicali
Milan, Italy
- Fondazione Centro San Raffaele del Monte Tabor
Milan, Italy
- National Institute for Infectious Diseases "l. Spallanzani" Irccs
Rome, Italy
- Clinical Research Puerto Rico, Inc.
San Juan, Puerto Rico
- Hospital Clinic I Provincial
Barcelona, Spain
- Hospital Germans Trias I Pujol
Barcelona, Spain
- Hospital General Universitario Gregorio Marañon
Madrid, Spain
- Hospital Ramon Y Cajal
Madrid, Spain
- Brighton and Sussex University Hospitals Nhs Trust
Brighton, East Sussex, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2010
- Primary completion
- 31 Jan 2012
- Completion
- 31 Oct 2014
- Last update posted
- 4 Dec 2015
- Registered enrollment
- 482
- Registry id
- NCT01252940
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.